Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Lilly ordered to pay $61M for shortchanging Medicaid drug rebate program

admin by admin
August 3, 2022
in Pharmaceutical



After nearly a decade of legal squabbling, Eli Lilly was ordered by a federal court jury to pay $61 million for shortchanging the Medicaid drug rebate program, the latest instance in which a drug company was accused of skimping on payments.

The company had been accused of failing to pay rebates from 2005 to 2016 and, consequently, making false statements to the U.S. Centers for Medicare and Medicaid Services about the prices it charged distributors for its drugs. The jury decided that Lilly intentionally underpaid rebates, resulting in a loss for the federal government program and Medicaid agencies in 26 states.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED





Source link

Previous Post

Pembrolizumab Combos Miss Primary Endpoints CA Trials

Next Post

COVID Symptoms Can Rebound Even Without Paxlovid: Study

Next Post

COVID Symptoms Can Rebound Even Without Paxlovid: Study

Recommended

Neighborhood May Affect a Couple’s Odds of Conceiving

August 4, 2022

To Gauge Monkeypox Spread, Researchers Eye Cases in Women

July 27, 2022

Don't miss it

Medicines & Healthy Lifestyle

Is the Latest Polio Scare Actually Caused by the Vaccine?

August 16, 2022
Pharmaceutical

Health Bulletin 16/August/2022

August 16, 2022
Medicines & Healthy Lifestyle

Sacituzumab Govitecan sBLA submitted for HR+/HER2- Metastatic Breast Cancer

August 16, 2022
Medicines & Healthy Lifestyle

Early Sexual Experiences Lead To Better Sexual Health In Adulthood, Study Shows

August 16, 2022
News

Early Dementia but No Specialists: Reinforcements Needed?

August 16, 2022
Pharmaceutical

Merck, a loser in Covid vaccine race, invests in Cambridge mRNA startup

August 16, 2022

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Wellness For Life News Hubb All rights reserved.